Medicine and Dentistry
Blood Proteins
100%
Coenzyme M
100%
Doxorubicin
100%
Serum Total Protein
38%
Anthracycline
23%
Tumor Necrosis Factor
23%
Therapeutic Procedure
23%
Sequela
15%
Toxicity
15%
Child
15%
Brain
7%
Chemotherapy Regimens
7%
Patient
7%
Antioxidant
7%
Non-Hodgkin Lymphoma
7%
Breast Cancer
7%
In Vitro
7%
Program Director
7%
Heart Injury
7%
Cystitis
7%
Combination Chemotherapy
7%
Drug
7%
Cancer Therapy
7%
Alkylating Antineoplastic Agent
7%
Animal Study
7%
Cancer Chemotherapy
7%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
7%
Stress
7%
Clinical Trial
7%
Clinical Study
7%
Drug Interaction
7%
Macrophage Cell Line
7%
Cells
7%
Cardiotoxicity
7%
Metronidazole
7%
Ifosfamide
7%
Antibodies
7%
Cardiovascular System
7%
Myocardial Disease
7%
Marker
7%
Chemotherapy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Coenzyme M
100%
Plasma Protein
100%
Tumor Necrosis Factor
23%
Anthracycline
23%
Animal
15%
Toxicity
15%
Chemotherapy
7%
Cardiotoxicity
7%
Ifosfamide
7%
Metronidazole
7%
Cancer Chemotherapy
7%
Alkylating Agent
7%
Malignant Neoplasm
7%
Nonhodgkin Lymphoma
7%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
7%
Cystitis
7%
Heart Injury
7%
Breast Cancer
7%
Clinical Study
7%
Chemotherapy Regimens
7%
Clinical Trial
7%
Drug
7%
Drug Interaction
7%
Antibodies
7%
Antioxidant
7%
Myocardial Disease
7%
Biochemistry, Genetics and Molecular Biology
Mesna
100%
Doxorubicin
100%
Blood Proteins
100%
Serum Total Protein
38%
Anthracycline
23%
Tumor Necrosis Factor
23%
Oxidation
15%
In Vitro Study
7%
Macrophage
7%
Animal Models
7%
Clinical Study
7%
Clinical Trial
7%
Animal Experiment
7%
Stress
7%
Drug Interaction
7%
Ifosfamide
7%
Antibodies
7%